BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mourenza Á, Gil JA, Mateos LM, Letek M. Novel Treatments against Mycobacterium tuberculosis Based on Drug Repurposing. Antibiotics (Basel) 2020;9:E550. [PMID: 32872158 DOI: 10.3390/antibiotics9090550] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Menshchikova EB, Kozhin PM, Chechushkov AV, Khrapova MV, Zenkov NK. The Oral Delivery of Water-Soluble Phenol TS-13 Ameliorates Granuloma Formation in an In Vivo Model of Tuberculous Granulomatous Inflammation. Oxid Med Cell Longev 2021;2021:6652775. [PMID: 34093961 DOI: 10.1155/2021/6652775] [Reference Citation Analysis]
2 Hoffmann AM, Wolke M, Rybniker J, Plum G, Fuchs F. In vitro Activity of Repurposed Nitroxoline Against Clinically Isolated Mycobacteria Including Multidrug-Resistant Mycobacterium tuberculosis. Front Pharmacol 2022;13:906097. [DOI: 10.3389/fphar.2022.906097] [Reference Citation Analysis]
3 Chauhan A, Kumar M, Kumar A, Kanchan K. Comprehensive review on mechanism of action, resistance and evolution of antimycobacterial drugs. Life Sci 2021;274:119301. [PMID: 33675895 DOI: 10.1016/j.lfs.2021.119301] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Berton S, Chen L, Liang YC, Xu Z, Afriyie-Asante A, Rajabalee N, Yang W, Sun J. A selective PPM1A inhibitor activates autophagy to restrict the survival of Mycobacterium tuberculosis. Cell Chem Biol 2022:S2451-9456(22)00094-0. [PMID: 35320734 DOI: 10.1016/j.chembiol.2022.03.006] [Reference Citation Analysis]
5 Lee C, Bhakta S. The Prospect of Repurposing Immunomodulatory Drugs for Adjunctive Chemotherapy against Tuberculosis: A Critical Review. Antibiotics (Basel) 2021;10:91. [PMID: 33477812 DOI: 10.3390/antibiotics10010091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Perveen S, Kumari D, Singh K, Sharma R. Tuberculosis drug discovery: Progression and future interventions in the wake of emerging resistance. Eur J Med Chem 2022;229:114066. [PMID: 34973508 DOI: 10.1016/j.ejmech.2021.114066] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
7 Olaifa K, Ajunwa O, Marsili E. Electroanalytic evaluation of antagonistic effect of azole fungicides on Acinetobacter baumannii biofilms. Electrochimica Acta 2022;405:139837. [DOI: 10.1016/j.electacta.2022.139837] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ramírez-Rendon D, Passari AK, Ruiz-Villafán B, Rodríguez-Sanoja R, Sánchez S, Demain AL. Impact of novel microbial secondary metabolites on the pharma industry. Appl Microbiol Biotechnol 2022. [PMID: 35188588 DOI: 10.1007/s00253-022-11821-5] [Reference Citation Analysis]